Robert W. Baird Boosts Longboard Pharmaceuticals (NASDAQ:LBPH) Price Target to $60.00
Longboard Pharmaceuticals (NASDAQ:LBPH – Free Report) had its target price hoisted by Robert W. Baird from $36.00 to $60.00 in a research report report published on Thursday morning, Benzinga reports. They currently have an outperform rating on the stock. Other research analysts have also issued reports about the company. B. Riley upped their price target […]
More Stories
Blackstone Mortgage Trust (NYSE:BXMT) Price Target Increased to $22.00 by Analysts at Wells Fargo & Company
Blackstone Mortgage Trust (NYSE:BXMT – Free Report) had its price target raised by Wells Fargo & Company from $19.00 to...
Truist Financial Boosts Banc of California (NYSE:BANC) Price Target to $16.00
Banc of California (NYSE:BANC – Free Report) had its price objective lifted by Truist Financial from $15.00 to $16.00 in...
Insider Selling: Nexstar Media Group, Inc. (NASDAQ:NXST) EVP Sells $472,717.44 in Stock
Nexstar Media Group, Inc. (NASDAQ:NXST – Get Free Report) EVP Blake Russell sold 2,782 shares of the business’s stock in...
Insider Selling: The Charles Schwab Co. (NYSE:SCHW) Director Sells $576,450.00 in Stock
The Charles Schwab Co. (NYSE:SCHW – Get Free Report) Director Carolyn Schwab-Pomerantz sold 9,000 shares of the company’s stock in...
Aris Mining Corporation (TSE:ARI) Director Sells C$309,522.00 in Stock
Aris Mining Corporation (TSE:ARI – Get Free Report) Director Douglas John Bowlby sold 47,400 shares of the business’s stock in...
Evergy (NYSE:EVRG) Now Covered by Analysts at Jefferies Financial Group
Jefferies Financial Group started coverage on shares of Evergy (NYSE:EVRG – Free Report) in a research report sent to investors...